In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Basics GmbH

Division of Sun Pharmaceutical Industries Ltd.
www.basics.de

Latest From Basics GmbH

Germany Blocks Cephalosporin Exports From Ranbaxy’s Dewas Unit

Ranbaxy is back in the news for GMP violations at its Dewas unit in India. Based on an inspection in June, this time Germany’s drug regulator has raised the red flag, citing deficiencies in design and clean room operations, among others. For its part, Ranbaxy clarified that it had decided to discontinue making injectable cephalosporins well before the joint inspection and that all its other facilities were cleared post the inspection.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Sun Pharmaceutical Industries Ltd.
  • Senior Management
  • Contact Info
  • Basics GmbH
    Phone: (49) 0214 403 9912
    Hemmelrather Weg 201
    Gebäude:GIZ 1
    Leverkusen, 51377
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register